Inhibikase Therapeutics (IKT) Shares Outstanding (2019 - 2026)
Inhibikase Therapeutics (IKT) posted Shares Outstanding of 174.57 million for Q2 2026, up 93.9% from 90.01 million a year earlier and up 1.3% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Shares Outstanding (2019 - 2026) Analysis & Trends
For FY2025, Inhibikase Therapeutics' Shares Outstanding came in at 98.31 million, up 314.6% from FY2024.
- Annual Shares Outstanding has increased for five consecutive years, with a five-year compound annual growth rate of 135.1% (FY2020 to FY2025).
- In prior years, Inhibikase Therapeutics' Shares Outstanding was 23.71 million in FY2024 (+344.6%), 5.33 million in FY2023 (+26.9%), 4.2 million in FY2022 (+38.5%) and 3.03 million in FY2021 (+121.7%).
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding in data going back to Q1 2020.
- On a year-over-year basis, Shares Outstanding has increased in each of the last four quarters, with growth averaging 304.3% over the last six quarters.
- Across the past five years, year-over-year growth in Shares Outstanding ran from 0.3% in Q3 2022 to 913.8% in Q3 2025.
- According to Business Quant data, Shares Outstanding for the three prior quarters was 172.31 million (Q1 2026), 98.31 million (Q4 2025) and 90.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 891.90 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.94 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.55 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 541.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Inhibikase Therapeutics | 281.11 Mn | -420.36 Mn | - | 181.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 181.36 Mn |
| Jun 30, 2026 | 174.57 Mn |
| Mar 31, 2026 | 172.31 Mn |
| Dec 31, 2025 | 98.31 Mn |
| Sep 30, 2025 | 90.05 Mn |
| Jun 30, 2025 | 90.01 Mn |
| Mar 31, 2025 | 89.54 Mn |
| Dec 31, 2024 | 23.71 Mn |
| Sep 30, 2024 | 8.88 Mn |
| Jun 30, 2024 | 7.54 Mn |
| Mar 31, 2024 | 6.34 Mn |
| Dec 31, 2023 | 5.33 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | 5.23 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Sep 30, 2022 | 4.20 Mn |
| Jun 30, 2022 | 4.20 Mn |
| Mar 31, 2022 | 4.20 Mn |
| Dec 31, 2021 | 3.03 Mn |
API Access
Inhibikase Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();